Global Pharmaceutical Asset Performance Management (APM) Market Growth (Status and Outlook) 2025-2031

Global Pharmaceutical Asset Performance Management (APM) Market Growth (Status and Outlook) 2025-2031

The global Pharmaceutical Asset Performance Management (APM) market size is predicted to grow from US$ 118 million in 2025 to US$ 163 million in 2031; it is expected to grow at a CAGR of 5.5% from 2025 to 2031.

Asset performance management (APM) is a proven approach to reduce unplanned downtime, decrease maintenance costs, and reduce EH&S risks.

Global Pharmaceutical Asset Performance Management (APM) key players include GE (U.S.), AVEVA Group plc (U.K.), AspenTech (U.S.), Rockwell Software (U.S.), SAP (Germany), etc. Global top five manufacturers hold a share over 65%.

North America is the largest market, with a share about 50%, followed by Europe and China, both have a share about 35 percent.

In terms of product, APM Integrity is the largest segment, with a share over 45%.

LPI (LP Information)' newest research report, the “Pharmaceutical Asset Performance Management (APM) Industry Forecast” looks at past sales and reviews total world Pharmaceutical Asset Performance Management (APM) sales in 2024, providing a comprehensive analysis by region and market sector of projected Pharmaceutical Asset Performance Management (APM) sales for 2025 through 2031. With Pharmaceutical Asset Performance Management (APM) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pharmaceutical Asset Performance Management (APM) industry.

This Insight Report provides a comprehensive analysis of the global Pharmaceutical Asset Performance Management (APM) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Pharmaceutical Asset Performance Management (APM) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Pharmaceutical Asset Performance Management (APM) market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pharmaceutical Asset Performance Management (APM) and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pharmaceutical Asset Performance Management (APM).

This report presents a comprehensive overview, market shares, and growth opportunities of Pharmaceutical Asset Performance Management (APM) market by product type, application, key players and key regions and countries.

Segmentation by Type:
Asset Integrity Management
Asset Reliability Management
Other

Segmentation by Application:
Large Enterprises
SMEs

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
GE (US)
Rockwell Software (US)
AVEVA Group plc (UK)
Bentley Systems (US)
AspenTech (US)
Nexus Global (US)
SAP (Germany)

Please note: The report will take approximately 2 business days to prepare and deliver.